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In situ characterization of advanced glycation
end products (AGEs) in collagen and model
extracellular matrix by solid state NMR†
R. Li,a R. Rajan,a W. C. V. Wong,a D. G. Reid, a M. J. Duer,*a V. J. Somovilla, ‡a
N. Martinez-Saez,‡a G. J. L. Bernardes, a R. Haywardb and C. M. Shanahanb
Non-enzymatic glycation of extracellular matrix with (U-13C5)-
D-ribose-5-phosphate (R5P), enables in situ 2D ssNMR identification
of many deleterious protein modifications and crosslinks, including
previously unreported oxalamido and hemiaminal (CH3–CH(OH)NHR)
substructures. Changes in charged residue proportions and distribution
may be as important as crosslinking in provoking and understanding
harmful tissue changes.
Glycation refers to spontaneously occurring non-enzymatic
reactions between biogenic aldehydes and ketones, in particular
the uncyclized forms of sugars, and biomolecular nucleophiles,
importantly the amino and guanidino side chains of protein Lys
and Arg.1 Glycation is initiated by Schiﬀ base formation followed
by Amadori rearrangement and thereafter a cascade of diverse
and much studied but still incompletely characterized so-called
‘‘Maillard’’ reactions. These can lead to adduction of basic groups
by acidic sugar glycoxidative breakdown products and thus
changes in protein structure, net charge and charge distribution,
and a variety of unnatural cross links between nearby residues.
The eﬀects of glycation are generally deleterious and result in
altered tissue mechanical properties such as stiﬀness and tensile
strength,2–4 net charge and charge distribution, and protein
binding recognition sites,5 resulting in altered molecular6,7 and
cellular8 recognition, and triggering of inflammatory processes
via the ‘‘receptor of advanced glycation end products’’, RAGE.9
Predictably glycation is more severe in hyperglycemic states such
as diabetes, and affects slow turnover macromolecules, such as
collagen, particularly markedly. Indeed glycation of connective
tissues, especially blood vessels constantly exposed to high levels
of circulating sugars, is a major factor underlying pathologies of
diabetes, as well as normal ageing.11–13 It is thus of great
biomedical importance to continue the characterization of
glycation processes leading to advanced glycation end products
(AGEs) and their effects on macroscopic and microscopic tissue
properties, and initiate an understanding of the effects of
glycation on biomolecular structure at the atomic level.
The complexity of the glycation process is compounded by
its proceeding with a distinct lack of consistency under apparently
consistent conditions, rendering pathways and structural con-
sequences of glycation extremely diﬃcult to study systematically
in vivo. This complexity is exacerbated by the occurrence of
reactions which are hard to predict even with simple model
compounds,14 and the poorly understood catalytic influence of
certain biomolecules and ions.15
Collagen is a major protein component of all vertebrate
tissues and the principle constituent of the extracellular matrix
(ECM) of connective tissue of bone, blood vessels, and numerous
other organs. Apart from the mechanical and structural roles of
the diﬀerent connective tissue collagen isoforms, they all perform
vital cell adhesion, motility, and signalling, roles the importance of
which is being increasingly appreciated.16 The collagens consist of
repeating triplet amino acid motifs –(Gly–X–Y)– in which X and Y
are frequently Pro and Hyp respectively, imposing a unique triple
helical secondary structure on the three polypeptide chains, which
comprises the fundamental building block of collagenous tissue,
including vascular smooth muscle (VSM) ECM. Collagen I triple
helices self-associate into larger scale fibrillary structures,
and additionally undergo a variety of orderly enzymatic post
translational modifications leading to glycosylations and cross
linking at specific residues.17
We have developed high yieldmethods of producing biomimetic
collagenous VSM cell (VSMC) ECM reproducibly in vitro. This
enables NMR active nuclei to be introduced into specific amino
acids, and studying of their structural environment, dynamics, and
chemistry, using powerful 2D (and potentially multidimensional)
solid state NMR methods impossible with unlabelled materials.
This provides a cost eﬀective, and ethical, alternative to in vivo
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methods for producing suﬃcient material for NMR. Equally
importantly it facilitates the incorporation of specific amino
acids, and sugars, (and in some cases, unavoidably, their
labelled metabolites) into matrix proteins for NMR structural
studies. We have used fetal sheep osteoblast (FSOb) ECM (FSOb-
ECM) enriched in U-13C,15N-labelled Gly and Pro, particularly
prevalent in collagen, to validate our use of in vitro material
against labelled native bone.18 By incorporating specific labelled
amino acids into in vitro ECM it is possible to address detailed
aspects of collagen and ECM molecular structure and how this
changes under glycation. Ultimately by glycating matrix labelled
with glycation target residues Lys, and Arg, with labelled sugar
reagents, identification of covalent AGE structures in situmay be
possible by ssNMR using similar atomic proximity-sensitive
techniques to those described below, without recourse to potentially
destructive degradative analyses.
A first step in this process requires the identification of
those NMR signals which arise from labelled glycating agent,
and which from labelled glycated protein. Accordingly this
communication reports 2D NMR characterization of labelled
products arising from reacting unlabelled native pure collagen,
and unlabelled in vitro VSMC ECM, with U-13C labelled D-ribose-
5-phosphate (U-13C5-R5P), an important intermediate in nucleic
acid and energy metabolism,19,20 and a vigorous endogenous
glycating agent.21,22
Materials and methods, including the synthesis of the
sodium salt of U-13C5-R5P from commercial U-
13C5-ribose, are
described in detail in ESI.†
Fig. 1 compares the 1D 13C CP-MAS spectra of pure collagen
and VSMC ECM before, and after, incubation with U-13C5-R5P.
There are close similarities between the spectra of the two
unreacted materials (Fig. S1a, ESI†), in particular the prominent
signal at ca. 70 ppm from the g-carbon atoms of Hyp, an
eﬀective NMR marker of collagenous tissue. It demonstrates
that collagen is the major component of the in vitro material,
with minor components of other integral ECM proteins, and
lipid. Incubation with U-13C5-R5P results in the appearance of a
number of new glycation product signals, which are qualitatively
quite similar for the twomaterials although the extent of production
of each is in many cases rather diﬀerent (Fig. S1b, ESI†). The
generation of new glycation product signals is clearly shown by a
comparison of the spectra of the glycated materials with those of
pure collagen, and of R5P, which are overlaid in Fig. S1c (ESI†). In
order to assign these NMR signals, we have used 2D single
quantum–double quantum (SQ–DQ) and proton driven spin
diffusion (PDSD) correlation techniques.
Accordingly Fig. 2 compares 2D SQ–DQ spectra of pure
collagen, and of VSMC ECM, reacted with U-13C5-R5P. As the
method depends on direct transfer mediated by the comparatively
weak 13C–13C dipolar interaction, cross peaks effectively imply that
the corresponding signals are from mutually bonded 13C atoms
and therefore must originate from U-13C5-R5P. These connecti-
vities are also probed by the PDSD experiment, which reveals longer
range proximities as well depending on the experimental spin
diffusion time. PDSD datasets, which essentially corroborate
the SQ–DQ data, for the two glycated materials are compared in
Fig. S2 (ESI†). Assignments are shown in Table 1, based in part
on published data for a number of common glycation products
(CEL,23 pentosinane, DOGDIC, and DOPDIC,24 glucosepane,
GODIC, MODIC, DOGDIC, GOLD, and MOLD,25 and CML26)
and strong cross peaks due to polyhydroxylated structures. A
cross peak attributable to a putative 5-phospho-ribuloselysine,
analogous to the initial ribuloselysine Amadori rearrangement
product of 13C5-ribose, is not observed because the 5-phosphate
group precludes cyclization to a stable furanose structure so this
intermediate progresses rapidly to more advanced products.21
Clear cross peaks in SQ–DQ spectra of both glycated materials
indicate the formation of a labelled fragment with two mutually
bonded carbon atoms with near equal chemical shifts of
ca. 165 ppm which we assign as part of an oxalate-derived
structure. A distinct SQ–DQ correlation in U-13C5-R5P glycated
collagen (not seen in VSMC ECM) between bonded carbons at
shifts of 22 ppm and 91 ppm is consistent with a hemiaminal
AGE substructure CH3CH(OH)NHR resulting from e.g. reaction
of acetaldehyde with Lys. In general the products of the reaction
between collagen and U-13C5-R5P qualitatively reproduce those
observed from reaction with U-13C5-ribose.
10 Although many
AGE structures observed by NMR are common to both pure
collagen and in vitro ECM there are quantitative differences,
most likely due to differences in overall protein composition,
and the accessibility of reactive groups to the glycating agents.
The in vitro ECM probably more closely replicates an in vivo
scenario as it would exist in the vasculature of a hyperglycemic
patient for instance, in containing a variety of other integral
ECM proteins besides type I collagen.
Glycation is usually quantified using the natural fluores-
cence of specific AGEs,27 and antibody probes raised against
Fig. 1 1D spectra of unlabelled collagen (a), and VSMC ECM (b) before
(black), and after (red), incubation with U-13C5-R5P. The Hyp g-carbon signal
unique to collagen is labelled g-O. The VSMC ECM material also shows
signals at ca. 30 ppm and ca. 130 ppm from cross-polarizing lipid (lip.).
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others.28 Such methods obviously depend on the AGEs of
interest being fluorescent in the first place, and the antigenicity
of specific already-known AGE structures or non-specific structures
resulting from glycation of an immunogenic protein, clearly
leaving potential gaps in the AGE detection armory. Besides this
many characterization approaches, for instance hyphenated
chromatography–mass spectrometry, rely on hydrolysis of insoluble
proteins such as collagen to constituent glycation-modified amino
acids under rather severe conditions such as high temperatures and
acidity; successful detection of certain AGEs thus clearly depends on
their stability under these conditions. While NMR is considerably
less sensitive than the above techniques it possesses the unique
advantage that it can be applied to native glycated material with
negligible pre-treatment and consequent possible decomposition,
while the use of non-perturbing isotope labelled glycating agents is
straightforward and greatly increases the atomic level information
content of resulting data. Moreover our approach is directly
applicable to other native biomaterials such as, importantly,
bone,29,30 and in vitro model ECM.
It is widely assumed that changes in the mechanical and
consequently biological properties of ECM are due mainly to
the introduction of AGE induced crosslinks. While signals
consistent with some cross linking structures (pentosinane,
DOGDIC, DOPDIC,MODIC, GODIC) are observed in ourmaterials,
our data suggests that the most abundant AGEs formed are rather
single amino acid residue modifications (CML, CEL, N-acetyl
species), and nitrogen adducts of single ribosyl (phosphate) units.
Such modifications convert basic protein functional groups into
charge neutral (N-acetyl, N-sugar adducts) or negative (CML, CEL)
substituents, with likely profound consequences for collagen triple
helical structure, interfibril associations, hydration, and molecular
recognition processes. Our results suggest that non-crosslinking,
monovalent glycation products may be at least as important as
AGE crosslinks in modifying ECM mechanical and molecular
recognition properties.
Dr Jonathan Clark of the Babraham Research Institute for
many helpful discussions; funding from the U.K. MRC (for DGR,
RR, RH), Royal Society (URF) and FCT Portugal (iFCT) (both for
GJLB), and for PhD studentships the China Scholarship Council
and Cambridge Trust (for RL), and U.K. EPSRC (for VWCW).
Fig. 2 SQ–DQ correlation spectra of collagen (a), and VSMC ECM (b),
after incubation with U-13C5-R5P. Correlations between significant glycation
products are marked in red; correlations between carbon atoms with identical
or very similar shifts are indicated *(vicinal diols) and **(hemiacetals,
hemiaminal functionalities). The diagonal line represents the SQ–DQ axis.
Table 1 Summary of the 13C–13C SQ–DQ and PDSD (100 ms spin diffusion mixing time) connectivities in pure collagen, and VSMC ECM, reacted with
13C5-R5P, and comparison with products previously identified in pure collagen reacted with (U-
13C5)-ribose
10
Cross peak correlations
Assignment VSMC Collagen U-13C5-ribose collagen
10Signal 1/ppm Signal 2/ppm
17 57 CEL and/or MODIC Yes Yes Yes
17 193 Norpronyl lysine Not obsd. Yes Not obsd.
21 173 N-Acetyls Yes Yes Yes
24 180 N-Acetyls Yes Not obsd.
22 91 CH3–CH(OH)NHR? Not obsd. Yes Not obsd.
37 59 DOPDIC/pentosinane Not obsd. Yes Yes
37 69 DOPDIC Weak Yes Not obsd.
50 172 CML Yes Yes Yes
57 176 CEL V. wk. Yes Yes
57 193 Norpronyl lysine Weak Yes Yes
62–84 62–84 Vicinal di-ols Yes Yes Yes
74 104 Hydroxylic-(hemi)acetal carbons Yes Yes Yes
64–73 178 DOGDIC, DOPDIC, MODIC, GODIC Yes Not certain Yes
88–92 Ca. 90 (Hemi)acetal/aminal Yes Yes Yes
165 165 Oxalic acid skeleton? Yes Yes Not obsd.
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